Showing results (301-310 of 456) with videos related to
Sort By:
Pageof 46
Lens and Eye Toxicity Research|January 1, 1989
Preservative effects on the healing rate of rabbit corneal epitheliumK Green, R E Johnson, J M Chapman, et al.Ear, Nose, & Throat Journal|March 25, 1999
Cranial polyneuropathies in multiple sclerosis: case report and literature reviewR W Thomas, D A Liening, A E Auber, et al.MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|August 13, 1993
An evaluation of surveillance for Chlamydia trachomatis infections in the United States, 1987-1991L A Webster, J R Greenspan, A K Nakashima, et al.Southern Medical Journal|April 1, 1996
Laryngoceles and saccular cystsJ C Sniezek, R E Johnson, S G Ramirez, et al.Clinical Pharmacology and Therapeutics|September 1, 1989
Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose inductionR E Johnson, E J Cone, J E Henningfield, et al.Pharmacoepidemiology and Drug Safety|April 10, 2004
Comparing the use of short-acting and long-acting calcium channel blockers in an HMOR E Johnson, D J Harrowe, B H McFarland, et al.Journal of the American Geriatrics Society|March 1, 1995
Medical care utilization among older HMO members with and without hypertensionL D Ried, R E Johnson, K K Brody, et al.Clinical Pharmacology and Therapeutics|March 1, 1991
Human pharmacology and abuse potential of nalmefeneP J Fudala, S J Heishman, J E Henningfield, et al.Life Sciences|January 1, 1991
Use of naloxone in the assessment of opiate dependenceP J Fudala, L C Berkow, J L Fralich, et al.The Annals of Pharmacotherapy|June 26, 1998
Beta-blockers and depression: the more the murkier?L D Ried, B H McFarland, R E Johnson, et al.Pageof 46